Literature DB >> 21039077

Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.

J M Ramos, M F García-Sepulcre, M Masiá, A Brotons, M C Grau, F Gutiérrez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21039077     DOI： 10.4321/s1130-01082010001000014

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


× No keyword cloud information.
  5 in total

1.  Septicemic listeriosis during adalimumab- and golimumab-based treatment for ulcerative colitis: case presentation and literature review.

Authors:  Ryoko Horigome; Hiroki Sato; Terasu Honma; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2019-06-20

2.  Listeriosis in patients receiving biologic therapies.

Authors:  M Bodro; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-09       Impact factor: 3.267

3.  Listeriosis in a Metropolitan Hospital: Is Targeted Therapy a Risk Factor for Infection?

Authors:  Fanfan Xing; Simon K F Lo; Susanna K P Lau; Patrick C Y Woo
Journal:  Front Med (Lausanne)       Date:  2022-04-29

4.  Listeria monocytogenes Meningitis in an Immunosuppressed Patient with Autoimmune Hepatitis and IgG4 Subclass Deficiency.

Authors:  Shahin Gaini
Journal:  Case Rep Infect Dis       Date:  2015-10-19

5.  Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis.

Authors:  Atsunori Tsuchiya; Shuji Terai
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.